Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VANDETANIB vs VASOPRESSIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VANDETANIB vs VASOPRESSIN: Safety Overview

Metric VANDETANIB VASOPRESSIN
Total FAERS Reports 1,159 1,953
Deaths Reported 93 801
Death Rate 8.0% 41.0%
Hospitalizations 363 1,195
Average Patient Age 53.6 yrs 60.6 yrs
% Female Patients 54.8% 27.2%
FDA Approval Date Apr 6, 2011 Approved Prior to Jan 1, 1982
Manufacturer Genzyme Corporation Sagent Pharmaceuticals
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued